Given the relationship between hypertriglyceridemia and CVD risk, it is not surprising that loss of function mutations in ApoC3 confer protection against the risk of ischemic vascular disease and atherosclerotic plaque development [39]. The gene discussed is APOC3; the disease is hypertriglyceridemia.